CXCL13 and neoplasm: Apart from the recruitment of tumor-infiltrating B cells, CXCL13, expressed by interleukin-6 (IL-6)-treated human bone marrow endothelial (HBME) cells, mediates PC-cell invasion, adhesion to HBME cells, and αvβ3-integrin clustering [88].